Immunovant, Inc.
NASDAQ:IMVTBiotechnology
Healthcare
$32.52 +2.00%
+$0.69 today
- Market cap
- $6.73B
- Beta
- 0.79
- P/E (TTM)
- -14.3
- EPS (TTM)
- -$2.48
52W Low $14.32High $36.29
Volume 0.73M
Average 1.84M
Price history
Immunovant, Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
+42.69%
Period high
$44.96
Period low
$22.02
Latest
$32.52
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| 4 | Nov 12, 2026 | Nov 12, 2026 | |
| 10-Q | Nov 9, 2026 | Nov 9, 2026 | |
| S-3ASR | Nov 9, 2026 | Nov 9, 2026 | |
| 8-K | Nov 9, 2026 | Nov 9, 2026 | |
| 4 | Oct 30, 2026 | Oct 30, 2026 | |
| 4 | Oct 23, 2026 | Oct 23, 2026 | |
| 4 | Oct 9, 2026 | Oct 9, 2026 | |
| 4 | Oct 9, 2026 | Oct 9, 2026 | |
| 4 | Oct 9, 2026 | Oct 9, 2026 | |
| 4 | Oct 5, 2026 | Oct 5, 2026 | |
| 4 | Sep 25, 2026 | Sep 25, 2026 | |
| 8-K | Sep 3, 2026 | Sep 3, 2026 | |
| 4 | Aug 28, 2026 | Aug 28, 2026 | |
| 4 | Aug 21, 2026 | Aug 21, 2026 | |
| SC 13G/A | Aug 14, 2026 | Aug 14, 2026 |
Competitors
Who does Immunovant, Inc. compete with?
Open similar companies to compare their filings and price history.
Competitors
Peer companies in the same sector
Questions
Filing questions
Common questions about IMVT's filings, answered from its disclosures.
What is the latest IMVT filing?
The latest filing shown is 4 dated Nov 12, 2026.
How many recent filings does IMVT have?
Intrinsic Alpha currently shows 20 recent filings for IMVT.
Continue the stock analysis
Jump to another research area for this company.